OS Therapies Incorporated (OSTX)
Healthcare
Biotechnology
1.60 $
+2.0%
vs. previous close
Closing price · As of: 3. Aug 2026
OS Therapies Incorporated (OSTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -14,239 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -2,413 | -4.4 | -3.8 | -3.0 | -7.3 | -14,239 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 363 | |
| – | – | – | 0.0 | 0.3 | 4,266 | |
| 964 | 0.6 | 0.9 | 2.0 | -0.1 | 9.1 | |
| 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | |
| 158 | 0.2 | 0.2 | 0.0 | – | -466 | |
| – | – | – | – | 31 | – | |
| – | – | – | – | – | 6,398 | |
| – | 3.0 | 3.8 | 3.2 | 1.5 | 0.0 | |
| 3,478 | 3.1 | 3.7 | 2.9 | 13 | 9,441 | |
| 1,233 | -1.2 | 0.1 | -0.1 | 5.5 | -5,264 | |
| -2,415 | -4.4 | -3.8 | -3.0 | -7.3 | -14,239 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.